Prosecution Insights
Last updated: October 25, 2026

Antoinette G Giugliano Pc

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials • Medical Devices & Mechanical Engineering

9 pending office actions • 4 clients • 8 examiners • 8 art units • 0 of 9 (0%) have an AI response strategy ready

Analysis

Antoinette G Giugliano PC has 9 pending office actions in Biotechnology & Pharmaceuticals and 321 career applications. Its resolved allowance rate is 82.3%, with an average of 2.72 office actions per allowance. The profile connects a small active docket with broader prosecution results.

The allowance rate provides outcome context, while the office-action average indicates the amount of examination activity associated with allowances. For practitioners, the data supports review of biotechnology and pharmaceutical claim strategies, especially how responses address substantive examination issues. Current matters can be assessed against the reported pattern without treating the figures as a prediction for any individual application.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=321 apps, methodology: how we score firms)

82.3%
Allowance Rate
n=321
+0.71σ
Allowance Rate (norm)
n=321
2.7
OAs to Allowance
n=186
-0.41σ
OAs to Allow (norm)
n=186
930 days
Time to Allowance
n=186
+15.3pp
Interview Lift
n=321
26.6%
RCE Rate
n=321
0.0%
Appeal Rate
n=321

Rejection Performance (% of received rejections ultimately overcome)

—
§101 Overcome
n=18 (min 20)
77.4%
§102 Overcome
n=62
76.5%
§103 Overcome
n=102
79.0%
§112 Overcome
n=124

Specialization & Scale

A61K, F26B, C12N
Top CPC Subclasses
31%
Top-3 CPC Share
n=321
1
Practitioners
n=321
321.0
Apps / Practitioner
n=321

Portfolio Summary

9
Total Pending OAs
5
Non-Final OAs
4
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

3
Overdue
0
Due this week
2
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (3)Due ≤ 30 days (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

3
Hard (33%)
4
Medium (44%)
2
Easy (22%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only2 (22%)
§102 only1 (11%)
§112 only1 (11%)
Double-patenting only1 (11%)
Double-patenting + other1 (11%)
Multi-statute (no §101)3 (33%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

6
Life Sciences
67% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
3
Mechanical / Eng
33% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

90 h
Manual time on pending OAs
18 h
Time saved (low, 20%)
31 h
Time saved (mid, 35%)
0.8 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
KOSAR, AARON J 2 71.3% +29.7%
PACKARD, BENJAMIN J 1 66.9% +15.3%
WILSON, GREGORY A 1 81.9% +6.9%
LAU, JASON 1 54.1% +15.9%
VIJAYARAGHAVAN, JAGAMYA NMN 1 61.0% +51.0%
PILCHER, JONATHAN L 1 64.3% +43.8%
MARTIN, PAUL C 1 41.8% +21.7%
GUINO-O UZZLE, MARITES A 1 69.2% +16.6%

Hard Cases (3)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
17779213 METHODS FOR PRODUCING CEMENT COMPRISING A SUPPLEMENTARY CEMENTITIOUS MATERIAL, AND CEMENT OBTAINABLE THEREBY GUINO-O UZZLE, MARITES A 120d overdue
18467089 Blood Plasma Product VIJAYARAGHAVAN, JAGAMYA NMN 26d
18846515 DEVICE AND METHOD FOR PRODUCING SUPPLEMENTARY CEMENTITIOUS MATERIALS WILSON, GREGORY A —

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17779213 METHODS FOR PRODUCING CEMENT COMPRISING A SUPPLEMENTARY CEMENTITIOUS MATERIAL, AND CEMENT OBTAINABLE THEREBY GUINO-O UZZLE, MARITES A 120d overdue
18791873 Alignment of A Disposable For A Spray Drying Plasma System LAU, JASON 43d overdue
17945126 Pretreatment Of Plasma For Spray Drying And Storage MARTIN, PAUL C 32d overdue
18467074 Pretreatment Of Plasma For Spray Drying And Storage PILCHER, JONATHAN L 16d
18467089 Blood Plasma Product VIJAYARAGHAVAN, JAGAMYA NMN 26d
19043319 Trans-Epithelial Membrane Drug Delivery System PACKARD, BENJAMIN J —
18745283 Formulations And Methods For Contemporaneous Stabilization Of Active Proteins During Spray Drying And Storage KOSAR, AARON J —
18406981 Process For Purification of Chemical Components From Plant Matter KOSAR, AARON J —

Client Portfolio (4 clients)

Top Art Units

Art UnitApps
37622
16121
16551
36531
16331
17721
16531
17311

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19043319 Trans-Epithelial Membrane Drug Delivery System John J. Masiz PACKARD, BENJAMIN J 1612 §103DP Non-Final OA — Pending Jan 31, 2025
18846515 DEVICE AND METHOD FOR PRODUCING SUPPLEMENTARY CEMENTITIOUS MATERIALS Cemgreen Aps WILSON, GREGORY A 3762 §102§112 Non-Final OA — Pending Sep 12, 2024
18791873 Alignment of A Disposable For A Spray Drying Plasma System Velico Medical, Inc. LAU, JASON 3762 §102Other Final Rejection 43d overdue Pending Aug 01, 2024
18745283 Formulations And Methods For Contemporaneous Stabilization Of Active Proteins During Spray Drying And Storage Velico Medical, Inc. KOSAR, AARON J 1655 DP Non-Final OA — Pending Jun 17, 2024
18406981 Process For Purification of Chemical Components From Plant Matter Kb Crash Creations LLC KOSAR, AARON J 3653 §112 Non-Final OA — Pending Jan 08, 2024
18467089 Blood Plasma Product Velico Medical, Inc. VIJAYARAGHAVAN, JAGAMYA NMN 1633 §103§112Other Final Rejection 26d Pending Sep 14, 2023
18467074 Pretreatment Of Plasma For Spray Drying And Storage Velico Medical, Inc. PILCHER, JONATHAN L 1772 §103 Final Rejection 16d Pending Sep 14, 2023
17945126 Pretreatment Of Plasma For Spray Drying And Storage Velico Medical, Inc. MARTIN, PAUL C 1653 §103 Final Rejection 32d overdue Pending Sep 15, 2022
17779213 METHODS FOR PRODUCING CEMENT COMPRISING A SUPPLEMENTARY CEMENTITIOUS MATERIAL, AND CEMENT OBTAINABLE THEREBY Cemgreen Aps GUINO-O UZZLE, MARITES A 1731 §103§112 Non-Final OA 120d overdue Pending May 24, 2022

Managing Antoinette G Giugliano Pc's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

What is Antoinette G Giugliano Pc's patent allowance rate?

82.3% of resolved applications prosecuted by Antoinette G Giugliano Pc were allowed, across 321 applications in USPTO records.

How many office actions does Antoinette G Giugliano Pc average before allowance?

2.72 office actions per allowed application on average.

How many pending office actions does Antoinette G Giugliano Pc have?

9 pending office actions as of October 2026, for 4 clients, before 8 examiners in 8 art units.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month